Americas malaria alert reveals POC testing Scope
This article was originally published in Clinica
Malaria diagnostics coverage in the Americas is a leading factor in the only patchy success of measures to tackle the disease and must be improved. So says a report presented at a meeting of ministers, hosted by the Pan American Health Organization (PAHO) last week in Washington.
You may also be interested in...
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
AstraZeneca's research head admits that the half dose approach was a lucky mistake – but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.